International Immunology Advance Access originally published online on February 4, 2008
International Immunology 2008 20(3):295-306; doi:10.1093/intimm/dxm141
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant antibodies for delivery of antigen: a single loop between β-strands in the constant region can accommodate long, complex and tandem T cell epitopes
1 Center for Immune Regulation, Institute of Immunology, Medical Faculty, University of Oslo and Rikshospitalet University Hospital, Norway
2 Department of Molecular Biosciences, University of Oslo, Oslo, Norway
Correspondence to: B. Bogen; E-mail: bjarne.bogen{at}medisin.uio.no
Recombinant antibodies are increasingly used for efficient delivery of T cell epitopes to antigen-presenting cells (APCs), both for vaccination purposes and for immune modulation. We have previously shown that recombinant antibodies can accommodate single T cell epitopes inserted into loops between β-strands in constant (C) domains. Such recombinant antibodies have in addition been equipped with variable regions that target APCs for increased delivery of C region T cell epitopes. We here show that loop 6 (loop FG) in CH1 of human
3 can be exchanged with (i) long T cell epitopes up to 37 amino acids, (ii) epitopes with complex secondary structure such as gluten epitopes with a type II polyproline helical confirmation and (iii) two tandemly linked T cell epitopes. T cell responses increased with T cell epitope elongation, presumably due to a positive influence of flanking residues. Recombinant antibodies targeted to either CD14 on monocytes or HLA-DP on monocytes and dendritic cells gave similar results and were 2–4 logs more efficient at stimulating human T cells than were non-targeted controls. Thus, single loops in C regions of recombinant antibodies seem versatile and may be used for delivery of lengthy, complex and multiple T cell epitopes to human APCs.
Keywords: autoimmunity, dendritic cells, human, monocytes/macrophages, vaccination
Transmitting editor: K. Inaba
Received 25 April 2006, accepted 6 December 2007.